Kayexalate

Indicated For

hyperkalemia

About This Medication

# No Manufacturer Patient Assistance Program for Kayexalate: Alternatives and Options Kayexalate (sodium polystyrene sulfonate), manufactured by Sanofi, does not have a dedicated patient assistance program (PAP). Sanofi's general PAPs, like Sanofi Patient Connection, do not list Kayexalate as a covered medication[1][3][10]. This guide explains your options for low or no-cost access, including Sanofi programs that may apply indirectly, state programs, and other resources. ## About Kayexalate **Kayexalate** is a prescription medication used to treat high levels of potassium in the blood, a condition called hyperkalemia. It works by binding to potassium in your digestive system and helping your body remove it through stool. It's often prescribed for people with kidney problems, heart failure, or those on certain medications that raise potassium levels. Common forms include powder or suspension, taken orally or as an enema. Always follow your doctor's instructions, as it can cause side effects like constipation, nausea, or rarely, serious bowel issues. While effective, Kayexalate can be expensive without insurance—costs often exceed $500 for a month's supply. Without a specific PAP, patients must explore alternatives[1]. ## Who Qualifies for Sanofi Assistance (General Programs) Sanofi offers programs like **Sanofi Patient Connection** for certain medications at no cost if eligible. However, Kayexalate is not listed among covered drugs in program details or product lists[1][3][4][10]. General eligibility includes: - U.S. resident under a U.S. licensed doctor's care. - Annual household income ≤**400%** of the Federal Poverty Level (FPL) for uninsured or functionally uninsured patients[1][7]. - No insurance coverage for the medication, or proof of denial (e.g., from Medicaid)[1]. Commercially insured patients may qualify if they lack coverage for the specific drug[1]. Medicare patients might appeal denials in cases of hardship[4][6]. ## Income Eligibility Breakdown Sanofi Patient Connection uses **400% FPL** for many programs (higher for some like CareASSIST at 500% or $100,000)[6][7]. Use the table below for 2026 estimates (FPL updates annually; check HHS.gov for exact figures). These apply to general Sanofi PAPs, not Kayexalate specifically. | Household Size | 100% FPL | 400% FPL | 500% FPL (select programs) | |----------------|----------|----------|----------------------------| | 1 | $15,060 | $60,240 | $75,300 | | 2 | $20,440 | $81,760 | $102,200 | | 3 | $25,820 | $103,280| $129,100 | | 4 | $31,200 | $124,800| $156,000 | *Add ~$5,380 per additional person for 100% FPL.* Income includes all household earnings. Provide tax returns or pay stubs for verification[1][7]. ## Insurance Requirements Sanofi's PAPs require **no insurance coverage** for the drug or proof of denial. Commercially insured patients must show the plan doesn't cover it. Medicare Part D patients may not qualify unless appealing a denial for hardship. Medicaid applicants need denial proof before PAP assessment[1][4][6]. Contact your insurer first to confirm coverage—Kayexalate may be generic and low-cost under many plans. ## Step-by-Step: Exploring Assistance Options 1. **Confirm Coverage**: Call your insurance (or Medicare at 1-800-MEDICARE) to check Kayexalate coverage. Request a denial letter if denied. 2. **Contact Sanofi Directly**: Call **888-847-4877** (Sanofi Patient Connection) or visit sanofipatientconnection.com. Ask if Kayexalate qualifies under any program—mention your doctor's involvement. Download the application by state[1][2][3]. 3. **Physician Involvement**: Your doctor completes part of the application, including a prescription. Mail to the address provided (e.g., PO Box 759, Somerville, NJ 08876)[4]. 4. **State and Federal Programs**: Apply for Medicaid/CHIP, state pharmaceutical aid, or 340B clinics. Use rxassist.org or needymeds.org for Kayexalate-specific help. 5. **Generic Alternatives**: Sodium polystyrene sulfonate is available generically—often cheaper. Pharmacy discount cards (GoodRx) can reduce costs to $50-100/month. 6. **Submit Documents**: Expect to provide ID, income proof (W-2s, tax returns), insurance denial, and doctor's form. ## Timeline and Delivery Processing takes 2-4 weeks after submission, but varies—no specific timeline for Kayexalate since no dedicated program[4]. If approved under a general PAP, medication ships to your doctor's office (not home)[4]. Refills require reapplication annually or as specified[4]. ## Alternatives if Denied or Ineligible - **Copay Programs**: Sanofi CareASSIST or HemAssist for insured patients (up to $25,000/year, but product-specific)[5][6][8]. Call 1-833-930-2273. - **Discounts**: GoodRx, SingleCare—search 'sodium polystyrene sulfonate coupon.' - **Patient Advocacy**: Partnership for Prescription Assistance (1-888-4PPA-NOW) or RxResource.org[4]. - **Hospital/Clinic Aid**: 340B programs or charity care. - **Biosimilars/Generics**: No biosimilars; use generic sodium polystyrene sulfonate[10]. - **Newer Drugs**: Ask your doctor about alternatives like patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma), which may have PAPs. ## Disclaimer This guide is for informational purposes only and not medical or legal advice. Eligibility and availability change; contact Sanofi (888-847-4877) or your healthcare provider for personalized help. FPL figures are estimates—verify current levels. Sanofi reserves rights to modify programs. No guarantee of coverage for Kayexalate[1][2]. (Word count: 942)

Program information last verified: March 30, 2026